Stock Taper Revenue: Q4 revenue increased by 6.8% year-on-year to EUR 70.2 million. Full-year revenue totaled EUR 268 million, flat compared to 2024.
Gross Profit: Q4 gross profit was EUR 40.8 million, yielding a gross margin of 58.1%. Full-year gross margin improved to 57.1%.
Profitability: Adjusted EBIT for Q4 was EUR 4 million (5.7% margin), a significant improvement from a loss of EUR 1.2 million in Q4 2024. Full-year adjusted EBIT reached EUR 10.6 million (4% margin).
Net Profit: Q4 net profit was EUR 6.2 million (EUR 0.11 per share), more than double last year’s EUR 2.9 million. Full-year net profit totaled EUR 7.7 million (EUR 0.13 per share).
Cash Flow: Positive free cash flow of EUR 4.5 million in Q4, with cash reserves at EUR 134 million and a net cash position of EUR 17.8 million.
Dual Listing: Materialise completed a dual listing on Euronext Brussels, enhancing operational flexibility and investor access.
Share Buyback Program: Announced a buyback program of up to EUR 30 million, with initial purchases completed.
Medical Segment Growth: Surpassed 700,000 patients treated with personalized solutions, with Q4 revenue from Medical growing over 16% to EUR 37 million.
Software Developments: Launched new CO-AM solutions and a new version of Mimics Flow, focusing on workflow automation and subscription pricing models.
Manufacturing Challenges: Consolidated online platforms to focus on professional 3D printing, while facing macroeconomic headwinds.
2026 Expectations: Revenue is projected to be between EUR 273 million and EUR 283 million. The Medical segment is expected to continue double-digit growth, while the Software segment will complete its transition to a cloud-based model.
Manufacturing Segment: Anticipated to face ongoing macroeconomic challenges, particularly in prototyping, but with potential growth in aerospace and defense sectors.
Manufacturing Decline: Revenue in the Manufacturing segment fell 2% in Q4 and 13% for the full year, with continued pressure from macroeconomic conditions.
Prototyping Impact: The prototyping segment remains a significant part of Manufacturing, which is declining, raising concerns about profitability in this area.
Operational Costs: Q4 operating expenses were higher due to nonrecurring costs related to the Euronext listing, which may affect future cost modeling.
Manufacturing Outlook: Management confirmed expectations of flat to declining revenue in Manufacturing for 2026 due to ongoing industrial market challenges.
Cost Management: There is an ongoing focus on cost optimization in the Manufacturing segment, with potential for improved margins in strategic sectors.
Operational Expenses: Q4 operating expenses included nonrecurring costs, suggesting a need for careful modeling of future expenses based on historical averages rather than Q4 figures alone. This summary encapsulates the key points from Materialise's Q4 2025 earnings call, highlighting financial performance, strategic initiatives, and challenges faced by the company.
SOURCE: Q4 2025 EARNINGS CALL TRANSCRIPT